Fangning B. Wan
No. 270 Dong' An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer.
Journal: Current gene therapy
Published: March 02, 2026
Correction: Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide.
Journal: Oncogene
Published: February 06, 2026
Study design and characteristics of participants in baseline investigation Zhejiang Childhood Behavior and Health Cohort
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: December 22, 2025
Preclinical and first-in-human evaluation of novel androgen receptor-targeted PET imaging in prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 04, 2025
FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner.
Journal: NPJ precision oncology
Published: October 07, 2024
IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathway.
Journal: International journal of biological sciences
Published: August 22, 2024
Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management.
Journal: Journal of the National Cancer Center
Published: April 30, 2024
Antifungal susceptibility of clinically isolated invasive Candida tropicalis in East China from 2017 to 2021
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: October 20, 2023
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
Journal: Molecular carcinogenesis
Published: December 20, 2022
Last Updated: 09/26/2026